Kimberly Barone Baden

Kimberly Barone Baden: Complex Personal Injury and Mass Tort Litigation Attorney in Mount Pleasant, South Carolina

As a strong advocate for the most defenseless members of society, Kimberly Barone Baden seeks accountability and compensation for victims of corporate misconduct, medical negligence, and harmful medical drugs. She manages mass tort pharmaceutical litigation through complex personal injury and economic damages cases.

Practice Areas

• Personal Injury Litigation - Plaintiffs
• Product Liability Litigation - Plaintiffs
• Mass Tort Litigation / Class Actions - Plaintiffs

Kimberly represents veterans, their families and civilians who were exposed to contaminated water at Marine Corps Base Camp Lejeune and were subsequently diagnosed with cancers and other illnesses. She also represents children exposed in utero to the contaminated water at Camp Lejeune who were born with severe birth defects.

Education & Credentials

• Firms: Motley Rice LLC
• Affiliations: American Association for Justice’s Section on Toxic, Environmental and Pharmaceutical Torts
• Recognized Since: Recognized in Best Attorney USA since 2020

Kimberly is recognized as an AV® rated attorney by Martindale-Hubbell®. She has served as co-lead counsel for In re Zofran (Ondansetron) Products Liability Litigation MDL 2657, held a seat on the PSC In re Zoloft (sertraline hydrochloride) Products Liability Litigation MDL 2342, and was appointed to the PEC for In re Viagra (Sildenafil Citrate) Products Liability Litigation MDL 269.

Kimberly has managed the firm's pharmaceutical litigation regarding Crestor®, Lipitor®, Actos®, Risperdal®, incretin mimetics, and dialysis products GranuFlo® Powder and NaturaLyte® Liquid acid concentrates. She also represents elderly victims of abuse and neglect, litigating cases against nursing homes and assisted living facilities.

Kimberly has spoken at numerous seminars, legal gatherings, CLEs and conferences across the U.S., addressing a broad range of topics related to pharmaceutical drugs and elder law litigation, focusing on MDL procedures, birth defects, nursing home litigation, discovery, trial strategy and mediation. Kimberly served as co-lead counsel for In re Zofran (Ondansetron) Products Liability Litigation MDL 2657, held a seat on the PSC In re Zoloft (sertraline hydrochloride) Products Liability Litigation MDL 2342, and was appointed to the PEC for In re Viagra (Sildenafil Citrate) Products Liability Litigation MDL 269.

Professional History

• Firms: Motley Rice LLC
• Affiliations: American Association for Justice’s Section on Toxic, Environmental and Pharmaceutical Torts
• Recognized Since: Recognized in Best Attorney USA since 2020

Kimberly is the former chair of the American Association for Justice’s Section on Toxic, Environmental and Pharmaceutical Torts. Prior to joining Motley Rice, she served as an attorney with the California District Attorney's Office in San Diego.

Education & Degrees

• Law School: California Western School of Law
• Bachelor’s Degree from Clemson University

Kimberly is recognized as an AV® rated attorney by Martindale-Hubbell®. She has served as co-lead counsel for In re Zofran (Ondansetron) Products Liability Litigation MDL 2657, held a seat on the PSC In re Zoloft (sertraline hydrochloride) Products Liability Litigation MDL 2342, and was appointed to the PEC for In re Viagra (Sildenafil Citrate) Products Liability Litigation MDL 269.

Kimberly has managed the firm's pharmaceutical litigation regarding Crestor®, Lipitor®, Actos®, Risperdal®, incretin mimetics, and dialysis products GranuFlo® Powder and NaturaLyte® Liquid acid concentrates. She also represents elderly victims of abuse and neglect, litigating cases against nursing homes and assisted living facilities.

Kimberly has spoken at numerous seminars, legal gatherings, CLEs and conferences across the U.S., addressing a broad range of topics related to pharmaceutical drugs and elder law litigation, focusing on MDL procedures, birth defects, nursing home litigation, discovery, trial strategy and mediation. Kimberly served as co-lead counsel for In re Zofran (Ondansetron) Products Liability Litigation MDL 2657, held a seat on the PSC In re Zoloft (sertraline hydrochloride) Products Liability Litigation MDL 2342, and was appointed to the PEC for In re Viagra (Sildenafil Citrate) Products Liability Litigation MDL 269.

Professional Affiliations

• American Association for Justice’s Section on Toxic, Environmental and Pharmaceutical Torts